[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Tina Banerjee posts on X about ipo, filed, $430m, spine the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance XXXX% currencies XXX% travel destinations XXX% stocks XXX% technology brands XXX%
Social topic influence ipo 2.6%, filed 1.3%, $430m 1.3%, spine 1.3%, investment 1.3%, $11b 1.3%, robot 1.3%, shanghai 1.3%, $6b 1.3%, samsung XXX%
Top posts by engagements in the last XX hours
"Brigade Hotel Ventures has filed for Indian IPO to raise up to INR 7596M. The company plans to sell 84.4M shares at between INR XX and INR XX per share. The IPO is set to open on July 24" @Generic_Tina on X 2025-07-24 02:58:00 UTC XX followers, XX engagements
"Artificial-intelligence-powered spine surgery developer Carlsmed is offering 6.7M shares priced between $XX and $XX apiece.At the mid-point the company is seeking a market value of $430M" @Generic_Tina on X 2025-07-22 00:35:21 UTC XX followers, XX engagements
"Hisamitsu's Q1FY26 revenue was down X% YoY due to subdued performance in Salonpas OTC products. However FY26 guidance was reiterated as Salonpas decline is seen as temporary" @Generic_Tina on X 2025-07-14 00:35:17 UTC XX followers, XX engagements
"Nanjing Leads Biolabs launches HK$1.1B IPO to fund its ongoing and planned clinical development and regulatory affairs of pipeline assets. The company has fetched cornerstone investment of HK$ 542M" @Generic_Tina on X 2025-07-18 00:35:13 UTC XX followers, XX engagements
"Shanghai MicroPort MedBot expects 7080% revenue growth in 1H25 with net loss narrowing to RMB 125M. Toumai Laparoscopic Surgical Robot is driving growth with new orders and overseas installations" @Generic_Tina on X 2025-07-23 00:35:24 UTC XX followers, XX engagements
"SK Bioscience initiates global Phase X trial of PCV21 vaccine. IDT Biologika shows revenue growth in 1Q25 on track to meet 2025 guidance. 1Q25 base business revenue increased XX% YoY" @Generic_Tina on X 2025-06-24 00:35:16 UTC XX followers, XX engagements
"3SBio signed $6B outlicensing deal with Pfizer for SSGJ-707 resulting in spectacular rally in 3SBio shares. Global trial initiation of SSGJ-707 and strong financial performance are expected ahead" @Generic_Tina on X 2025-07-01 00:35:15 UTC XX followers, XXX engagements
"Samsung Biologics reported strong 2Q25 result with consolidated revenue and operating profit rising XX% and X% YoY respectively. The company has raised 2025 revenue growth guidance to 2530% YoY" @Generic_Tina on X 2025-07-25 00:35:16 UTC XX followers, XX engagements
"Celltrion's 1Q25 results show a sequential decrease in revenue and operating profit but a sequential improvement in gross profit margin. The company reaffirmed its 2025 revenue guidance of KRW5T" @Generic_Tina on X 2025-07-21 05:58:40 UTC XX followers, XX engagements